vimarsana.com

Latest Breaking News On - Phoenix biotech acquisition daily - Page 1 : vimarsana.com

Periscope Capital Inc Sells 400,059 Shares of Phoenix Biotech Acquisition Corp (NASDAQ:PBAX)

Periscope Capital Inc Sells 400,059 Shares of Phoenix Biotech Acquisition Corp (NASDAQ:PBAX)
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Phoenix Biotech Acquisition (NASDAQ:PBAX) Trading 1 8% Higher

Phoenix Biotech Acquisition (NASDAQ:PBAX) Trading 1 8% Higher
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Phoenix Biotech Acquisition Corp (NASDAQ:PBAX) Short Interest Update

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Get Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 800 shares, an increase of 700.0% from the June 15th total of 100 shares. Approximately 0.1% of the company’s shares are short sold. Based on […]

Phoenix Biotech Acquisition Corp (NASDAQ:PBAXU) Sees Significant Drop in Short Interest

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU – Get Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 100 shares, a drop of 50.0% from the June 15th total of 200 shares. Based on an average daily volume of 100 […]

Short Interest in Phoenix Biotech Acquisition Corp (NASDAQ:PBAXU) Rises By 100 0%

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU – Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 200 shares, an increase of 100.0% from the May 31st total of 100 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.